Martis Capital, a $1.2 billion private equity fund, has invested in DCN Diagnostics, a specialist diagnostics developer co-founded by Irish biotech entrepreneur Brendan O’Farrell.  O’Farrell co-founded the business in 2003 and currently serves as its president. DCN specialises in developing rapid diagnostics tests for infectious diseases like Covid-19. The financial terms of the investment deal by Martis in the company were not disclosed. Since its first product in 2006, DCN has developed over 100 rapid diagnostic tests for its customers which range from larger manufacturers to non-profits to start-ups. O’Farrell co-founded the business after working for ten years for other…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .